Cross-fund · 6 holders
VRTX
VERTEX PHARMACEUTICALS INC
CUSIP 92532F100
6
Tracked holders
$22.01B
Aggregate value
48,922,718
Shares
6
Active funds
Funds holding VRTX
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $10.93B | 0.16% | −111,042 | −0.5% |
| BlackRock | Institutional | Q1 2026 | $10.70B | 0.19% | +217,528 | +0.9% |
| Citadel | Multi-Strategy | Q1 2026 | $282.0M | 0.05% | −158,462 | −20.1% |
| Millennium | Multi-Strategy | Q1 2026 | $81.4M | 0.03% | −305,641 | −62.6% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $9.0M | 0.01% | −7,900 | −28.1% |
| BridgewaterFEAT | Macro | Q1 2026 | $6.0M | 0.03% | −14,131 | −51.4% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.